Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.15B |
| 2 |
Tesla
TSLA
|
+$1.26B |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$610M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$482M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$461M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$667M |
| 2 |
iShares Floating Rate Bond ETF
FLOT
|
+$652M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 4 |
Meta Platforms (Facebook)
META
|
+$583M |
| 5 |
iShares MSCI United Kingdom ETF
EWU
|
+$507M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.96% |
| 2 | Consumer Discretionary | 3.1% |
| 3 | Financials | 1.5% |
| 4 | Healthcare | 1.15% |
| 5 | Communication Services | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
National Vision
EYE
$1.81B
| $3.12M | ﹤0.01% |
128,607
+13,970
| +12% | +$325K |
|
3402
CALL
AdaptHealth
AHCO
$759M
| $3.12M | ﹤0.01% |
256,600
-150,300
| -37% | -$1.68M |
|
|
SAGE
3403
PUT
DELISTED
Sage Therapeutics
SAGE
| $3.12M | ﹤0.01% |
+66,400
| New | +$3.3M |
|
3404
CALL
Vail Resorts
MTN
$5.3B
| $3.12M | ﹤0.01% |
12,400
-8,700
| -41% | -$2.12M |
|
3405
BondBloxx Bloomberg Twenty Year Target Duration US Treasury ETF
XTWY
$252M
| $3.12M | ﹤0.01% |
66,344
+36,243
| +120% | +$1.72M |
|
3406
Kymera Therapeutics
KYMR
$8.94B
| $3.12M | ﹤0.01% |
135,624
+70,850
| +109% | +$2.03M |
|
3407
PUT
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.2B
| $3.12M | ﹤0.01% |
+124,600
| New | +$3.26M |
|
3408
Insmed
INSM
$28.6B
| $3.11M | ﹤0.01% |
147,538
+87,684
| +146% | +$1.66M |
|
3409
EPR Properties
EPR
$4.77B
| $3.11M | ﹤0.01% |
+66,400
| New | +$2.8M |
|
3410
PUT
Sinclair Inc
SBGI
$1.03B
| $3.11M | ﹤0.01% |
+224,700
| New | +$3.71M |
|
3411
CALL
Tidewater
TDW
$4.12B
| $3.1M | ﹤0.01% |
56,000
+12,100
| +28% | +$554K |
|
3412
CALL
iShares Convertible Bond ETF
ICVT
$7.35B
| $3.1M | ﹤0.01% |
102,500
-81,600
| -44% | -$5.95M |
|
3413
Invesco DB US Dollar Index Bearish Fund
UDN
$109M
| $3.1M | ﹤0.01% |
164,983
-21,042
| -11% | -$396K |
|
|
GTM
3414
CALL
ZoomInfo Technologies
GTM
$1.22B
| $3.1M | ﹤0.01% |
122,100
-15,800
| -11% | -$374K |
|
3415
CALL
MSCI
MSCI
$40.9B
| $3.1M | ﹤0.01% |
6,600
-5,300
| -45% | -$2.59M |
|
3416
Invesco DB Base Metals Fund
DBB
$315M
| $3.1M | ﹤0.01% |
172,513
+75,243
| +77% | +$1.41M |
|
3417
PUT
Intellia Therapeutics
NTLA
$1.67B
| $3.1M | ﹤0.01% |
75,900
+54,500
| +255% | +$2.21M |
|
3418
iShares International Small Cap Equity Factor ETF
ISCF
$681M
| $3.09M | ﹤0.01% |
100,304
+30,093
| +43% | +$936K |
|
3419
SiTime
SITM
$21.8B
| $3.09M | ﹤0.01% |
26,200
-78,113
| -75% | -$8.52M |
|
3420
Equitable Holdings
EQH
$14.1B
| $3.09M | ﹤0.01% |
113,670
-171,055
| -60% | -$4.33M |
|
3421
JPMorgan BetaBuilders US Treasury Bond 3-10 Year ETF
BBIB
$54.2M
| $3.09M | ﹤0.01% |
+31,497
| New | +$3.13M |
|
3422
PUT
Robinhood
HOOD
$83.9B
| $3.08M | ﹤0.01% |
309,100
-183,000
| -37% | -$1.7M |
|
3423
PUT
Inspire Medical Systems
INSP
$1.74B
| $3.08M | ﹤0.01% |
9,500
+7,400
| +352% | +$2.11M |
|
3424
CALL
Toro Company
TTC
$9.49B
| $3.08M | ﹤0.01% |
30,300
+2,200
| +8% | +$226K |
|
|
SIX
3425
DELISTED
Six Flags Entertainment Corp.
SIX
| $3.08M | ﹤0.01% |
118,543
-165,976
| -58% | -$4.29M |
|
Similar funds
Jane Street's Q2 2023 Portfolio in Review
As of Q2 2023, Jane Street held 10,215 positions worth $297B, up 22% from $244B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jane Street deployed $26.9B of net new capital in Q2 2023, opening 1,302 new positions and adding to 3,894 existing holdings. Its largest new stake was Kenvue: 10,291,011 shares worth $272M.
By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 2.5% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.
- Jane Street's largest Q2 2023 buy was Kenvue: 10,291,011 shares worth $272M.
- Jane Street added most to Apple in Q2 2023, an estimated $2.15B increase.
- Jane Street's biggest Q2 2023 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
- Jane Street fully exited JPMorgan BetaBuilders Europe ETF in Q2 2023, selling an estimated $325M.
- Jane Street's ten largest holdings make up 36% of its $297B portfolio in Q2 2023.
- Jane Street opened 1,302 new positions and closed 1,631 in Q2 2023.
- Jane Street's portfolio value rose 22% quarter-over-quarter to $297B.
Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.